1-Year Follow up to the 1473-IMIQ Study
This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a placebo cream for the treatment of AK.
|Study Design:||Observational Model: Defined Population
Time Perspective: Longitudinal
|Official Title:||A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00114023
|United States, Arkansas|
|Little Rock, Arkansas, United States, 72205|